Children are especially at risk for infection.
The study also focuses on postpartum individuals and their babies.
Kids aren’t just little adults—they need COVID-19 clinical trials too.
Immunological research on IL-17 produces breakthrough.
The Pitt scientist presents on drug-resistant HIV in PrEP users.
Researchers are testing the therapy for patients with advanced melanoma that is tough to treat.
The doctor of medicine program curricular infrastructure combines a lecture-and problem-based curriculum with early and in-depth clinical experiences and an integrated organ systems approach to the pre-clinical sciences.
Our school’s leadership team—helmed by Anantha Shekhar—is committed to supporting a learning environment that positions tomorrow’s physicians to lead lives of impact.
We look for applicants who are leaders and who balance academic achievement with an abiding sense of personal discovery and a deep commitment to serving others.
We are proud of our long tradition of research excellence and training by world-class faculty members committed to mentoring the next generation of medical professionals.
Tomorrow's breakthroughs depend directly on today's advances in basic research. We stand among the nation's leading centers of basic and applied biomedical research.
At the University of Pittsburgh School of Medicine, we teach and train doctors to handle the realities of a new era in medicine.